![An image showing a [2]catenane](https://d2cbg94ubxgsnp.cloudfront.net/Pictures/274x183/0/0/4/504004_fja0c01757_0007.jpeg_49119.jpg)
All Employment articles
View all stories with this category.
-
SponsoredSellafield
At Sellafield, we’re true pioneers. We led the world in nuclear power production, now we’re the world’s first movers into environmental remediation
-
-
Sponsored
Hyper Recruitment Solutions
From creating life-saving drugs to life-changing technologies, making a difference through candidates is in our DNA
-
Sponsored
Defence Science and Technology Laboratory
Harnessing science and technology to protect the UK, and the rest of the world too
-
RSC
The Royal Society of Chemistry
Whether exploring the elements or the science of technology, chemical scientists improve health, the environment and daily life
-
-
Sponsored
AstraZeneca
Making medicines that change people’s lives is what AstraZeneca does, and so could you
-
Careers
Harnessing the power: AstraZeneca apprentices
How an AstraZeneca apprentice solved the business-wide problem of drug compound solubility
-
Careers
Apprentice insight
Scientists share insights on Reading Scientific Service Limited’s apprenticeship scheme and advise their former selves
-
Opinion
Reviewing performance reviews
Assessing the value of researchers’ work is hard, but there are some easy ideas to avoid
-
Business
Pfizer to close two manufacturing plants in India
Closures will lead to the loss of 1700 jobs – almost 6% of the pharma giant’s manufacturing workforce
-
Business
Novartis to cut over 2000 jobs
Move exemplifies a wave of manufacturing cuts as pharma moves to more high-value, specialised medicines
-
Business
Novartis exit from antibiotics a setback for race against resistance
Experts say business models must change to halt big pharma exodus
-
News
Apotex chief executive steps down amid tumult at generics firm
President and chief executive of Canada’s biggest generic drugmaker resigns the same day that police announce its founder and his wife were murdered
-
Business
Dementia slips down pharma agenda
Pfizer, Shire, Acorda and Axovant rethink their neuroscience strategies
-
Business
Teva to cut 14,000 jobs
Saddled with debt in an increasingly competitive generic drug industry, the Israel-headquartered giant begins a difficult transformation
-
Business
Pharmaceuticals roundup 2017
Political influence has strongly shaped industry activity in the past year
-
Business
Merck & Co and Qiagen to build UK research hubs
Almost 2000 jobs to be created at research centres in Manchester and London
-
Business
European drug regulator heads to Amsterdam
Brexit drives EMA to relocate, taking hundreds of jobs and significant expertise away from UK
-
Business
Russia backs new research cluster
Government touts high-tech science area as Russia’s answer to Silicon Valley
